20 April, 2023 – CBC Group (“CBC”), Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limited (“Hasten”), today jointly announced the completion of a US$315 million fundraising round for Hasten. Hasten is an innovation-driven pharmaceutical company backed by CBC, Hefei Industry Investment Group, and Feidong County of Hefei City.

The year of 2022 marked the 70th anniversary of the Patriotic Health Movement (Be shorted as ‘the movement’). On December 27, the 2022 National Patriotic Health Campaign Conference, with the theme of "70 years’ Patriotic Health Movement, Healthy China Tour - advocating a civilized, healthy, sustainable and environmental lifestyle, and helping to normalize epidemic prevention and control", was successfully held in Beijing.

Shanghai, December 16, 2022 - Aon Group, a global leading professional services firm, recently released its list of 2022 Best ESG Employers in China. Hasten Biopharma was awarded the " 2022 Aon China Best ESG Employer Agile Organization Award" for its efforts on sustainable organization building and innovation achievements.

On the morning of Nov. 23, the groundbreaking ceremony for Hasten Biopharma Hefei Production Base project (Yi Bo Sen Pharmaceutical Co., Ltd.) was held in Feidong, Hefei. Yuan Fei, member of the Standing Committee of Hefei Municipal Committee, attended the ceremony and announced the full start of the project. Summer Xia, CEO of Hasten Biopharma, Jiang Xin, General Manager of Hefei Industry Investment Group and Chairman & General Manager of Hefei Industry Investment Capital, Yao Fei, Secretary of Feidong County, Zhang Hong, CEO of RMB Business Group of CBC Group, Annie Lee, Chairman of the Board of Directors of Hasten Biopharma and Managing Director of CBC Group, Zhang Bo, Managing Director of CBC Broup and Director of Hasten Biopharma were present. Vice Governor of Feidong County, Ma Juanshu, hosted the ceremony. Representatives from related institutions of Feidong County and Hefei City participate in the start-up activities.

Hasten Biopharma and Sinopharm Group Jiangsu Company Limited signed a strategic cooperation agreement in Suzhou Jiangsu Province on September 27th 2022. The two companies will work together to create a closed-loop medical service by using innovative digital marketing methods, enhance the coverage of digital platform through the efficient commercialization capability of Sinopharm Jiangsu, and assist patients in the whole course of health management.

Hasten Bioparma and Jointown Pharmaceutical Group Co. (Jointown Group) signed a strategic cooperation agreement. The two companies will work together to build an out-of-hospital chronic disease management ecosystem, enhance retail terminal coverage through efficient commercialization capabilities, improve out-of-hospital patient access to medicines, and work together to benefit more patients with chronic diseases.